西班牙裔与非西班牙裔的慢性肾脏病进展与死亡率
在慢性肾功能不全队列(CRIC)与西班牙裔CRIC研究的前瞻性纵向分析中,共纳入3785名参与者(西班牙裔13%、非西班牙裔白人43%、非西班牙裔黑人44%),西班牙裔中位随访5.1年、非西班牙裔6.8年。西班牙裔的CKD进展、新发ESRD和eGFR年下降率显著高于非西班牙裔白人(P<0.05),但与黑人无显著差异;调整后西班牙裔与白人或黑人的CKD进展风险无差异,但在非糖尿病患者中西班牙裔较黑人CKD进展和ESRD风险更低,尿蛋白较高时西班牙裔死亡风险显著低于非西班牙裔。
要点
- 西班牙裔的CKD进展、新发ESRD和eGFR年下降率显著高于非西班牙裔白人,但与黑人无显著差异。
- 调整后西班牙裔与白人或黑人的CKD进展风险无显著差异。
- 非糖尿病患者中西班牙裔较黑人CKD进展风险更低(HR 0.61,95%CI 0.39-0.95)、ESRD风险更低(HR 0.50,95%CI 0.30-0.84)。
核心结论
- 西班牙裔与非西班牙裔在CKD进展和死亡率方面存在重要差异,可能受蛋白尿和糖尿病影响。
研究设计与样本
- 前瞻性纵向分析,纳入慢性肾功能不全队列(CRIC)与西班牙裔CRIC研究的3785名参与者,其中西班牙裔13%、非西班牙裔白人43%、非西班牙裔黑人44%。
主要发现
- 西班牙裔中位随访5.1年、非西班牙裔6.8年,全体参与者中27.6%发生CKD进展、21.3%达到新发ESRD、18.3%死亡。
- 西班牙裔的CKD进展率、新发ESRD率和eGFR年均下降幅度显著高于非西班牙裔白人(P<0.05),但与黑人无显著差异。
- 西班牙裔死亡率与非西班牙裔白人相似,但低于非西班牙裔黑人(P<0.05)。
- 调整后西班牙裔与白人及黑人的CKD进展风险无显著差异。
- 非糖尿病患者中,西班牙裔较黑人CKD进展风险更低(HR 0.61,95%CI 0.39-0.95)、新发ESRD风险更低(HR 0.50,95%CI 0.30-0.84)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Although recommended approaches to CKD management are achieved less often in Hispanics than in non-Hispanics, whether long-term outcomes differ between these groups is unclear. In a prospective longitudinal analysis of participants enrolled into the Chronic Renal Insufficiency Cohort (CRIC) and Hispanic-CRIC Studies, we used Cox proportional hazards models to determine the association between race/ethnicity, CKD progression (50% eGFR loss or incident ESRD), incident ESRD, and all-cause mortality, and linear mixed-effects models to assess differences in eGFR slope. Among 3785 participants, 13% were Hispanic, 43% were non-Hispanic white (NHW), and 44% were non-Hispanic black (NHB). Over a median follow-up of 5.1 years for Hispanics and 6.8 years for non-Hispanics, 27.6% of all participants had CKD progression, 21.3% reached incident ESRD, and 18.3% died. Hispanics had significantly higher rates of CKD progression, incident ESRD, and mean annual decline in eGFR than did NHW (P<0.05) but not NHB. Hispanics had a mortality rate similar to that of NHW but lower than that of NHB (P<0.05). In adjusted analyses, the risk of CKD progression did not differ between Hispanics and NHW or NHB. However, among nondiabetic participants, compared with NHB, Hispanics had a lower risk of CKD progression (hazard ratio, 0.61; 95% confidence interval, 0.39 to 0.95) and incident ESRD (hazard ratio, 0.50; 95% confidence interval, 0.30 to 0.84). At higher levels of urine protein, Hispanics had a significantly lower risk of mortality than did non-Hispanics (P<0.05). Thus, important differences in CKD progression and mortality exist between Hispanics and non-Hispanics and may be affected by proteinuria and diabetes.
引用
- Fischer MJ, Hsu JY, Lora CM, et al. CKD Progression and Mortality among Hispanics and Non-Hispanics. J Am Soc Nephrol. 2016. PMID: 27151925
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。